Malignant effusions and immunogenic tumour-derived exosomes (Q44082514)

29 November 2017

Malignant effusions and immunogenic tumour-derived exosomes (English)

1 reference

29 November 2017

12

1 reference

29 November 2017

14

1 reference

29 November 2017

15

Laurence Zitvogel

1 reference

29 November 2017

11

Thomas Tursz

0 references

Caroline Flament

4

object named as

Caroline Flament

0 references

Bernard Escudier

9

object named as

Bernard Escudier

1 reference

29 November 2017

Philippe Morice

6

0 references

Thierry Le Chevalier

10

object named as

Thierry Le Chevalier

1 reference

29 November 2017

13

Graca Raposo

1 reference

29 November 2017

Fabrice Andre

1

1 reference

29 November 2017

Noel E C Schartz

2

1 reference

29 November 2017

Mojgan Movassagh

3

1 reference

29 November 2017

Caroline Flament

4

1 reference

29 November 2017

Patricia Pautier

5

1 reference

29 November 2017

Christophe Pomel

7

1 reference

29 November 2017

Catherine Lhomme

8

1 reference

29 November 2017

Thomas Tursz

11

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

360

1 reference

29 November 2017

295-305

1 reference

29 November 2017

9329

1 reference

Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

B lymphocytes secrete antigen-presenting vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Adoptive immunotherapy for advanced cancer patients using in vitro activated cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909552-1

7 January 2021

10.1016/S0140-6736(02)09552-1

Identifiers

DOI

1 reference

29 November 2017

1 reference